DA
Doliver Advisors’s Pfizer PFE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-5,934
| Closed | -$218K | – | 153 |
|
|
2023
Q2 | $218K | Hold |
5,934
| – | – | 0.07% | 153 |
|
|
2023
Q1 | $242K | Buy |
5,934
+1,150
| +24% | +$46.9K | 0.08% | 144 |
|
|
2022
Q4 | $245K | Buy |
+4,784
| New | +$245K | 0.08% | 133 |
|
|
2022
Q3 | – | Sell |
-9,459
| Closed | -$496K | – | 162 |
|
|
2022
Q2 | $496K | Buy |
+9,459
| New | +$496K | 0.18% | 84 |
|
|
2021
Q4 | – | Sell |
-16,354
| Closed | -$703K | – | 176 |
|
|
2021
Q3 | $703K | Buy |
16,354
+1,186
| +8% | +$51K | 0.24% | 76 |
|
|
2021
Q2 | $594K | Buy |
15,168
+4,275
| +39% | +$167K | 0.2% | 81 |
|
|
2021
Q1 | $395K | Buy |
10,893
+800
| +8% | +$29K | 0.15% | 94 |
|
|
2020
Q4 | $372K | Buy |
10,093
+1,550
| +18% | +$57.1K | 0.16% | 90 |
|
|
2020
Q3 | $314K | Buy |
8,543
+418
| +5% | +$15.4K | 0.16% | 111 |
|
|
2020
Q2 | $266K | Buy |
8,125
+740
| +10% | +$24.2K | 0.12% | 108 |
|
|
2020
Q1 | $283K | Sell |
7,385
-300
| -4% | -$11.5K | 0.14% | 87 |
|
|
2019
Q4 | $301K | Sell |
7,685
-566
| -7% | -$22.2K | 0.12% | 81 |
|
|
2019
Q3 | $301K | Buy |
8,251
+2,126
| +35% | +$77.6K | 0.12% | 79 |
|
|
2019
Q2 | $265K | Hold |
6,125
| – | – | 0.1% | 93 |
|
|
2019
Q1 | $260K | Buy |
6,125
+270
| +5% | +$11.5K | 0.11% | 75 |
|
|
2018
Q4 | $256K | Sell |
5,855
-102
| -2% | -$4.46K | 0.13% | 99 |
|
|
2018
Q3 | $263K | Buy |
+5,957
| New | +$263K | 0.11% | 117 |
|